Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Dan Suesskind is an Israeli investor and director who previously served as the Chief Financial Officer of Teva Pharmaceutical Industries Ltd. for 32 years. He has served on the boards of various companies, including Teva, Migdal, Ness Technologies Ltd., and Syneron Medical Ltd. In 2008, he co-launched a fund with Professor Shlomo Ben-Haim to invest in medical devices and potentially pharmaceutical companies.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Dan Suesskind's primary investment focus by sector?
- Dan Suesskind primarily focuses on the Health Tech & Life Sciences sector, with one recorded investment in this area.
- Has Dan Suesskind made any recent investments?
- Dan Suesskind's most recent recorded investment was in January 2020.
- Which company is a notable portfolio company for Dan Suesskind?
- Butterfly Medical, an implantable device company for nonsurgical BPH treatment, is a notable portfolio company for Dan Suesskind.
- What was the funding stage and amount for Butterfly Medical?
- Butterfly Medical raised a $30M Series C round, in which Dan Suesskind participated.
- What is Dan Suesskind's typical investment stage?
- Dan Suesskind has participated in an A Round, indicating an interest in early-stage investments.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2008-7 |
|---|